FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35725811000001107: Xeljanz 10mg tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Sep 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
109528301000001114 Xeljanz 10mg tablets (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109528401000001118 Xeljanz 10mg tablets (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xeljanz 10mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Is a Tofacitinib 10mg tablets true Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Has active ingredient Tofacitinib true Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Has specific active ingredient Tofacitinib false Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Is a Xeljanz true Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Has specific active ingredient Tofacitinib citrate true Inferred relationship Existential restriction modifier
Xeljanz 10mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tofacitinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xeljanz 10mg tablets (Pfizer Ltd) 56 tablet 4 x 14 tablets Has AMP True Xeljanz 10mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start